Navigating uncertainty: a valuable cost-effectiveness analysis in the rapidly changing field of metastatic melanoma treatment

Br J Dermatol. 2015 Dec;173(6):1365-6. doi: 10.1111/bjd.14306.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cost-Benefit Analysis*
  • Humans
  • Melanoma
  • Quality-Adjusted Life Years
  • Uncertainty*